Entry |
|
Name |
Eplivanserin (USAN/INN) |
Formula |
C19H21FN2O2
|
Exact mass |
328.1587
|
Mol weight |
328.38
|
Structure |

|
Efficacy |
Hypnotic |
Comment |
Treatment of insomnia
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR2A
D10006 Eplivanserin (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 24
1 C8x C 19.3200 -22.2600
2 C8x C 19.3200 -23.6600
3 C8x C 20.5100 -24.3600
4 C8x C 21.7700 -23.6600
5 C8y C 21.7700 -22.2600
6 C8y C 20.5100 -21.5600
7 X F 22.9600 -21.5600
8 C2c C 20.5100 -20.1600
9 C2b C 19.3200 -19.4600
10 N2b N 21.7000 -19.4600
11 C2b C 18.1300 -20.1600
12 C8y C 16.9400 -19.4600
13 C8x C 16.9400 -18.0600
14 C8x C 15.6800 -17.3600
15 C8y C 14.4900 -18.0600
16 C8x C 14.4900 -19.4600
17 C8x C 15.6800 -20.1600
18 O1a O 13.3000 -17.3600
19 O2a O 22.8900 -20.1600
20 C1b C 24.0800 -19.4600
21 C1b C 25.2700 -20.1600
22 N1c N 26.4600 -19.4600
23 C1a C 27.6500 -20.1600
24 C1a C 26.4600 -18.0600
BOND 25
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 6 8 1
9 8 9 1
10 8 10 2
11 9 11 2
12 11 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 12 17 1
19 15 18 1
20 10 19 1
21 19 20 1
22 20 21 1
23 21 22 1
24 22 23 1
25 22 24 1
|